We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Overview of the UK's cancer research infrastructure and the advantages of investing in the UK's life science sector to develop new treatments.
For the first time, patients with certain types of advanced or recurrent endometrial cancer could access a treatment shown to slow its progression
Annual report on improving cancer outcomes.
This workbook was developed by the Health Inequalities National Support Teams (HINST) with 70 local authorities covering populations in England.
Quarterly updates to the emergency presentations of cancer data by Public Health England.
Projects granted during 2014 that have a primary purpose of translational and applied research: human cancer.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (27 December) approved the advanced melanoma medicine Opdualag (nivolumab-relatlimab) for patients from the age of 12.
RIDA funds research and development in new technologies, and new approaches to existing technologies, that support Sustainable Development Goals in south-east Asia.
A report on whether appropriate assessment of older cancer patients would result in better access to cancer treatment.
Survivors can be ostracized from their communities, shunned by their families, denied justice and cut off from support networks. This can prevent community reconciliation and wider post-conflict stabilisation which is why the focus of the PSVI over the coming years...
High quality care is critical to improving cancer outcomes. While this country has many of the elements required to collect, analyse and publish information; there are also deficiencies in cancer intelligence.
DASA seeks innovations to enhance operational advantage through improved self suffiency and energy innovation
Projects granted during 2015 that have a primary purpose of translational and applied research: projects on human cancer.
Projects granted during 2015 that have a primary purpose of basic research: oncology.
Patients with recurring lymphoma, or who have not responded to prior treatments, could access a new bispecific antibody therapy to help treat their condition.
Information on the programme, including commissioning, quality assurance, education and training.
National targeted lung cancer screening programme designed to catch cancer sooner announced.
Findings from a retrospective study at a tertiary care cancer centre in rural Kerala, India.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.